Catherine Cusack Acquires 1,000 Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Stock

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Director Catherine Cusack acquired 1,000 shares of the stock in a transaction dated Friday, February 21st. The stock was acquired at an average cost of $16.43 per share, with a total value of $16,430.00. Following the transaction, the director now owns 59,083 shares of the company’s stock, valued at approximately $970,733.69. This trade represents a 1.72 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Catherine Cusack also recently made the following trade(s):

• On Monday, February 24th, Catherine Cusack bought 1,500 shares of Sabra Health Care REIT stock. The shares were acquired at an average price of $15.92 per share, for a total transaction of $23,880.00.

Sabra Health Care REIT Stock Up 3.4 %

Shares of NASDAQ:SBRA traded up $0.54 during trading on Tuesday, hitting $16.42. The company’s stock had a trading volume of 2,299,149 shares, compared to its average volume of 2,080,510. The company has a market capitalization of $3.91 billion, a PE ratio of 30.98, a PEG ratio of 1.97 and a beta of 1.25. The stock’s 50-day moving average price is $16.82 and its two-hundred day moving average price is $17.63. The company has a debt-to-equity ratio of 0.88, a quick ratio of 4.16 and a current ratio of 4.32. Sabra Health Care REIT, Inc. has a fifty-two week low of $13.31 and a fifty-two week high of $20.03.

Sabra Health Care REIT (NASDAQ:SBRA) last issued its quarterly earnings data on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share for the quarter, meeting the consensus estimate of $0.36. The firm had revenue of $182.35 million for the quarter, compared to the consensus estimate of $178.01 million. Sabra Health Care REIT had a net margin of 18.02% and a return on equity of 4.60%. As a group, sell-side analysts expect that Sabra Health Care REIT, Inc. will post 1.45 EPS for the current year.

Sabra Health Care REIT Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 28th. Shareholders of record on Friday, February 14th will be issued a $0.30 dividend. The ex-dividend date is Friday, February 14th. This represents a $1.20 annualized dividend and a dividend yield of 7.31%. Sabra Health Care REIT’s dividend payout ratio is currently 226.42%.

Institutional Investors Weigh In On Sabra Health Care REIT

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Rockefeller Capital Management L.P. raised its position in shares of Sabra Health Care REIT by 4.5% during the third quarter. Rockefeller Capital Management L.P. now owns 15,369 shares of the real estate investment trust’s stock worth $286,000 after purchasing an additional 655 shares during the period. Assetmark Inc. increased its stake in Sabra Health Care REIT by 33.4% in the 4th quarter. Assetmark Inc. now owns 2,618 shares of the real estate investment trust’s stock worth $45,000 after purchasing an additional 656 shares in the last quarter. Janney Montgomery Scott LLC increased its stake in Sabra Health Care REIT by 0.4% in the 4th quarter. Janney Montgomery Scott LLC now owns 177,161 shares of the real estate investment trust’s stock worth $3,068,000 after purchasing an additional 763 shares in the last quarter. Focus Partners Wealth raised its holdings in Sabra Health Care REIT by 4.0% during the 4th quarter. Focus Partners Wealth now owns 20,771 shares of the real estate investment trust’s stock worth $360,000 after buying an additional 797 shares during the period. Finally, Louisiana State Employees Retirement System lifted its stake in Sabra Health Care REIT by 1.2% during the fourth quarter. Louisiana State Employees Retirement System now owns 65,700 shares of the real estate investment trust’s stock valued at $1,138,000 after buying an additional 800 shares in the last quarter. Institutional investors and hedge funds own 99.40% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently commented on the stock. Citizens Jmp raised shares of Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 7th. JMP Securities raised shares of Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price target for the company in a research report on Tuesday, January 7th. Mizuho reissued a “neutral” rating and set a $20.00 price target on shares of Sabra Health Care REIT in a research report on Thursday, December 5th. Finally, Truist Financial downgraded Sabra Health Care REIT from a “buy” rating to a “hold” rating and cut their price objective for the stock from $18.00 to $17.00 in a report on Friday, January 17th. Three analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $18.86.

About Sabra Health Care REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.